Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-07-20 Sale |
2022-07-21 4:10 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
5,602 | $1.4223 | $7,968 | 43,689 (Direct) |
View |
2022-07-20 Sale |
2022-07-21 4:09 pm |
CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer |
5,602 | $1.4219 | $7,965 | 31,898 (Direct) |
View |
2022-07-20 Sale |
2022-07-21 4:08 pm |
CytomX Therapeutics Inc. | CTMX | Campoy Carlos Chief Financial Officer |
3,949 | $1.4224 | $5,617 | 39,972 (Direct) |
View |
2021-06-16 Sale |
2021-06-21 3:51 pm |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
100,000 | $7.0447 | $704,470 | 100,967 (Indirect Direct) |
View |
2021-03-31 Sale |
2021-04-02 5:37 pm |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
100,000 | $7.4947 | $749,470 | 299,037 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-07-19 Option Award |
2022-07-21 4:10 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
15,000 | $0 | 43,689 (Direct) |
View |
2022-07-19 Option Award |
2022-07-21 4:09 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer |
15,000 | $0 | 31,898 (Direct) |
View |
2022-07-19 Option Award |
2022-07-21 4:08 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Campoy Carlos Chief Financial Officer |
15,000 | $0 | 39,972 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:07 pm |
N/A 2032-06-14 |
CytomX Therapeutics Inc. | CTMX | Young Matthew P. Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:07 pm |
N/A 2032-06-14 |
CytomX Therapeutics Inc. | CTMX | Mohindru Mani Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:06 pm |
N/A 2032-06-14 |
CytomX Therapeutics Inc. | CTMX | Meyers James R Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:06 pm |
N/A 2032-06-14 |
CytomX Therapeutics Inc. | CTMX | Gilbert Halley E Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:05 pm |
N/A 2032-06-14 |
CytomX Therapeutics Inc. | CTMX | GLUCK FREDERICK W Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:04 pm |
N/A 2032-06-14 |
CytomX Therapeutics Inc. | CTMX | Jones Elaine V Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:04 pm |
N/A 2032-06-14 |
CytomX Therapeutics Inc. | CTMX | Ashworth Alan Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-05-09 Exercise |
2022-05-11 4:51 pm |
N/A 2023-02-25 |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
90,931 | $0 | 359,011 (Direct) |
View |
2022-05-09 Exercise |
2022-05-11 4:51 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
90,931 | $0.945 | 359,011 (Direct) |
View |
Ownership |
2022-03-28 4:12 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer |
0 | $0 | 451,465 (Indirect) |
View |
Ownership |
2022-03-09 6:06 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Ogden Christopher See Remarks |
0 | $0 | 89,863 (Direct) |
View |
2022-02-02 Option Award |
2022-02-04 4:53 pm |
N/A 2032-02-01 |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
240,000 | $0 | 246,421 (Direct) |
View |
2022-02-02 Option Award |
2022-02-04 4:52 pm |
N/A 2032-02-01 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
157,500 | $0 | 169,291 (Direct) |
View |
2022-02-02 Option Award |
2022-02-04 4:51 pm |
N/A 2032-02-01 |
CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer |
157,500 | $0 | 157,500 (Direct) |
View |
2022-02-02 Option Award |
2022-02-04 4:50 pm |
N/A 2032-02-01 |
CytomX Therapeutics Inc. | CTMX | Campoy Carlos Chief Financial Officer |
157,500 | $0 | 163,921 (Direct) |
View |
2022-02-02 Option Award |
2022-02-04 4:49 pm |
N/A 2032-02-01 |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
525,000 | $0 | 718,080 (Direct) |
View |
2021-10-24 Option Award |
2021-10-26 4:30 pm |
N/A 2031-10-23 |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
180,000 | $0 | 180,000 (Direct) |
View |
2021-10-24 Option Award |
2021-10-26 4:29 pm |
N/A 2031-10-23 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
70,000 | $0 | 70,000 (Direct) |
View |
2021-10-24 Option Award |
2021-10-26 4:26 pm |
N/A 2031-10-23 |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2021-10-24 Option Award |
2021-10-26 4:25 pm |
N/A 2031-10-23 |
CytomX Therapeutics Inc. | CTMX | Campoy Carlos Chief Financial Officer |
70,000 | $0 | 70,000 (Direct) |
View |
2021-10-24 Option Award |
2021-10-26 4:24 pm |
N/A 2031-10-23 |
CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer |
70,000 | $0 | 70,000 (Direct) |
View |
2021-09-29 Option Award |
2021-10-07 5:12 pm |
N/A 2031-09-28 |
CytomX Therapeutics Inc. | CTMX | Ashworth Alan Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-08-11 Exercise |
2021-08-13 5:22 pm |
N/A 2021-09-20 |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
92,113 | $0 | 193,080 (Direct) |
View |
2021-08-11 Exercise |
2021-08-13 5:22 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
92,113 | $1.1339 | 193,080 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:48 pm |
N/A 2031-06-15 |
CytomX Therapeutics Inc. | CTMX | Mohindru Mani Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:47 pm |
N/A 2031-06-15 |
CytomX Therapeutics Inc. | CTMX | Young Matthew P. Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:46 pm |
N/A 2031-06-15 |
CytomX Therapeutics Inc. | CTMX | SCARLETT JOHN A Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:45 pm |
N/A 2031-06-15 |
CytomX Therapeutics Inc. | CTMX | Meyers James R Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:44 pm |
N/A 2031-06-15 |
CytomX Therapeutics Inc. | CTMX | Jones Elaine V Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:43 pm |
N/A 2031-06-15 |
CytomX Therapeutics Inc. | CTMX | GLUCK FREDERICK W Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:43 pm |
N/A 2031-06-15 |
CytomX Therapeutics Inc. | CTMX | Gilbert Halley E Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-06-14 Exercise |
2021-06-16 9:49 pm |
N/A 2021-09-20 |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
40 | $0 | 359,822 (Direct) |
View |
2021-06-14 Exercise |
2021-06-16 9:49 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
30 | $1.1339 | 359,822 (Direct) |
View |
2021-06-14 Exercise |
2021-06-16 9:49 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
10 | $0.945 | 359,822 (Direct) |
View |
2021-05-31 Option Award |
2021-06-08 1:08 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Campoy Carlos Chief Financial Officer |
3,320 | $6.086 | 6,421 (Direct) |
View |
2021-05-31 Option Award |
2021-06-08 1:07 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
3,320 | $6.086 | 6,421 (Direct) |
View |
2021-03-31 Exercise |
2021-04-02 5:37 pm |
N/A 2021-09-20 |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
100,000 | $0 | 299,037 (Direct) |
View |
2021-03-31 Exercise |
2021-04-02 5:37 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
100,000 | $1.1339 | 299,037 (Direct) |
View |
2021-02-26 Option Award |
2021-03-02 5:07 pm |
N/A 2031-02-25 |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
250,000 | $0 | 250,000 (Direct) |
View |
2021-02-26 Option Award |
2021-03-02 5:01 pm |
N/A 2031-02-25 |
CytomX Therapeutics Inc. | CTMX | Campoy Carlos Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |